Avaliação do desempenho e da sustentabilidade do programa de rastreamento organizado do câncer de mama implementado em São Paulo

• Processo: 25/05545-2
• Modalidade de apoio: Bolsas no Exterior - Estágio de Pesquisa - Pós-Doutorado
• Data de Início da vigência: 01 de janeiro de 2026
• Data de Término da vigência: 31 de dezembro de 2026
• Área de conhecimento: Ciências da Saúde - Saúde Coletiva - Saúde Pública
• Pesquisador responsável: Victor Wünsch Filho
• Beneficiário: Alice Barros Câmara
• Supervisor: Andre Lopes Carvalho
• Instituição Sede: Fundação Oncocentro de São Paulo (FOSP). Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brasil
• Instituição Anfitriã: International Agency for Research on Cancer (IARC), França
• Vinculado à bolsa: 22/15539-1 - Transição de programa oportunístico de rastreamento do câncer de mama para organizado no estado de São Paulo, BP.PD
• Palavra(s)-Chave do Pesquisador: Breast cancer screening | Long-term sustainability | Performance Indicators | Population-based screening program | Rastreamento de câncer

Resumo

Breast cancer (BC) is the leading cause of cancer-related deaths among women in Brazil, with an age-standardized mortality rate of 12 deaths per 100,000. Around 40% of BC diagnoses in the country occur at advanced stages (TNM III-IV), disproportionately affecting brown and black women with lower education levels. Recent data indicated an increasing trend in BC mortality in São Paulo, following more than two decades of declines. In response, the ConeCta-SP (Cancer Control in the State of São Paulo) project was launched in 2022 to establish an organized and population-based screening programs for cervical and breast cancer in São Paulo. The initiative addresses key barriers to BC screening through specific strategies, such as optimizing workflow organization, training healthcare teams, actively reaching the target population, increasing public awareness, and fostering partnerships with companies, universities, and schools. Additionally, a monitoring platform is being implemented to track screened women, facilitating follow-up and reducing delays in diagnosis and treatment. As part of ConeCta-SP, this proposal aims to continuously evaluate the performance of the implemented BC screening program using key indicators, including: mammography coverage; participation rate; proportion of exams performed outside the target age population and recommended screening intervals; compliance with follow-up assessment; rates of true-positive, false-positive, and inconclusive mammography results; and time from positive screening to diagnosis. This proposal will contribute to the assessment of evidence-based strategies aimed at enhancing the long-term sustainability and scalability of the organized BC screening program within São Paulo's public health system. (AU)